We are live on
!
Find out more
EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$5.05B
AUM Growth
-$270M
(-5.1%)
Cap. Flow
-$24.2M
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
17.38%
Holding
782
New
110
Increased
316
Reduced
268
Closed
85
Avg Time Held
7.4
quarters
Top 10 Avg Time Held
1.6
quarters
Top 20 Avg Time Held
3.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FORG
ForgeRock, Inc.
FORG
|
+$51M |
| 2 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$48.8M |
| 3 |
MAG
MAG Silver
MAG
|
+$26.3M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$20.1M |
| 5 |
Sundial Growers
SNDL
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cloudflare
NET
|
+$24.8M |
| 2 |
Vector Group Ltd.
VGR
|
+$24.8M |
| 3 |
Organigram Holdings
OGI
|
+$19M |
| 4 |
ZIXI
Zix Corporation
ZIXI
|
+$16.4M |
| 5 |
American Express
AXP
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 49.84% |
| 2 | Materials | 13.94% |
| 3 | Healthcare | 10.24% |
| 4 | Financials | 7.61% |
| 5 | Miscellaneous | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CDAK
651
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $74K | ﹤0.01% |
6,761
-1,007
| -13% | -$14K |
2020 Q4
4 quarters
|
|
652
ARS Pharmaceuticals
SPRY
$399M
| $70K | ﹤0.01% |
10,605
-1,204
| -10% | -$9.78K |
2021 Q1
3 quarters
|
|
653
Angi Inc
ANGI
$248M
| $68K | ﹤0.01% |
+734
| New | +$79.4K |
2021 Q4
0 quarters
|
|
|
PRTK
654
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $68K | ﹤0.01% |
15,173
-2,000
| -12% | -$9.49K |
2020 Q2
6 quarters
|
|
655
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $66K | ﹤0.01% |
+3,022
| New | +$69.2K |
2021 Q4
0 quarters
|
|
|
ABTC
656
American Bitcoin Corp
ABTC
$579M
| $65K | ﹤0.01% |
+1
| New | +$75.5K |
2021 Q2
2 quarters
|
|
657
Atossa Therapeutics
ATOS
$26.4M
| $64K | ﹤0.01% |
+2,563
| New | +$93.8K |
2021 Q4
0 quarters
|
|
658
DELISTED
Redfin
RDFN
| $62K | ﹤0.01% |
+1,578
| New | +$71.7K |
2021 Q4
0 quarters
|
|
|
ATHX
659
DELISTED
Athersys, Inc. Common Stock
ATHX
| $62K | ﹤0.01% |
2,845
-292
| -9% | -$8.38K |
2020 Q2
6 quarters
|
|
660
Paysign
PAYS
$845M
| $61K | ﹤0.01% |
36,052
-600,204
| -94% | -$1.29M |
2019 Q2
10 quarters
|
|
661
InflaRx
IFRX
$221M
| $59K | ﹤0.01% |
13,354
-2,780
| -17% | -$11.2K |
2021 Q1
3 quarters
|
|
662
DELISTED
Tricon Residential Inc.
TCN
| $59K | ﹤0.01% |
+3,905
| New | +$55.6K |
2021 Q4
0 quarters
|
|
663
Radian Group
RDN
$4.38B
| $57K | ﹤0.01% |
+2,683
| New | +$59.4K |
2021 Q4
0 quarters
|
|
664
Compass
COMP
$6.53B
| $56K | ﹤0.01% |
+6,088
| New | +$66.7K |
2021 Q4
0 quarters
|
|
665
CorMedix
CRMD
$576M
| $54K | ﹤0.01% |
11,510
-2,660
| -19% | -$13.2K |
2020 Q2
6 quarters
|
|
666
Immunome
IMNM
$2.09B
| $51K | ﹤0.01% |
3,658
-542
| -13% | -$9.67K |
2021 Q1
3 quarters
|
|
667
Inseego
INSG
$71.6M
| $50K | ﹤0.01% |
860
-89
| -9% | -$5.79K |
2020 Q2
6 quarters
|
|
668
Tonix Pharmaceuticals
TNXP
$114M
| – | – |
0
| – | – |
2021 Q1
3 quarters
|
|
669
DELISTED
Enzo Biochem, Inc.
ENZ
| $47K | ﹤0.01% |
14,651
-2,625
| -15% | -$8.96K |
2020 Q2
6 quarters
|
|
670
Backblaze
BLZE
$722M
| $42K | ﹤0.01% |
+2,420
| New | +$53.6K |
2021 Q4
0 quarters
|
|
671
DELISTED
Edgio, Inc. Common Stock
EGIO
| $39K | ﹤0.01% |
279
-16
| -5% | -$1.9K |
2020 Q2
6 quarters
|
|
672
iBio
IBIO
$51.8M
| $38K | ﹤0.01% |
132
-21
| -14% | -$8.01K |
2020 Q2
6 quarters
|
|
|
PHAS
673
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $38K | ﹤0.01% |
14,536
-2,636
| -15% | -$7.97K |
2020 Q2
6 quarters
|
|
674
Xunlei
XNET
$314M
| $34K | ﹤0.01% |
16,653
-73
| -0.4% | -$191 |
2020 Q3
5 quarters
|
|
675
Assembly Biosciences
ASMB
$417M
| $33K | ﹤0.01% |
1,206
-162
| -12% | -$5.31K |
2020 Q2
6 quarters
|
|
Similar funds
AIA
PFM
DKP
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q4 2021 Portfolio in Review
As of Q4 2021, ETF Managers Group held 782 positions worth $5.05B, down 5.1% from $5.32B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
ETF Managers Group's Q4 2021 filing shows 110 new, 316 increased, 268 reduced and 85 closed positions. Its largest new stake was ForgeRock, Inc.: 1,766,365 shares worth $47.9M. The largest sale was Cloudflare, an estimated $24.8M.
By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 47% a quarter earlier, followed by Materials and Healthcare.
- ETF Managers Group's largest Q4 2021 buy was ForgeRock, Inc.: 1,766,365 shares worth $47.9M.
- ETF Managers Group added most to MAG Silver in Q4 2021, an estimated $26.3M increase.
- ETF Managers Group's biggest Q4 2021 reduction was Cloudflare, cutting an estimated $24.8M.
- ETF Managers Group fully exited Zix Corporation in Q4 2021, selling an estimated $16.4M.
- ETF Managers Group's ten largest holdings make up 17% of its $5.05B portfolio in Q4 2021.
- ETF Managers Group opened 110 new positions and closed 85 in Q4 2021.
- ETF Managers Group's portfolio value fell 5.1% quarter-over-quarter to $5.05B.
Based on ETF Managers Group's 13F filing for Q4 2021, filed 14 Feb 2022.